From: Obstetric prognosis in sisters of preeclamptic women – implications for genetic linkage studies
reference group | unaffected sisters of preeclamptic index patients | affected sisters of preeclamptic index patients | |
---|---|---|---|
characteristics | N = 530 | N = 63 | N = 42 |
Pregnancy-induced hypertension | 3 (0.57 %) | 1 (1.59 %) P = 0.365a | 3 (7.14 %) P < 0.001a |
Placental abruption | 2 (0.38 %) | 0 P = 1.00a | 1 (2.38 %) P = 0.205a |
Placenta previa | 4 (0.75 %) | 2 (3.17 %) P = 0.126a | 0 P = 1.00a |
Prolonged gravidarum (>42 w) | 39 (7.36 %) | 6 (9.52 %) P = 0.612a | 1 (2.38 %) P = 0.346a |
Female fetus | 261 (49.25 %) | 30 (47.62 %) P = 0.807 | 23 (54.76 %) P = 0.491 |
Isoimmunization (Rh) | 1 (0.19 %) | 0 P = 1.00a | 0 P = 1.00a |
Low hemoglobin concentration (< 100 g/L) | 7 (1.32 %) | 0 P = 1.00a | 0 P = 1.00a |
Cesarean delivery | 97 (18.30 %) | 9 (14.29 %) P = 0.432 | 14 (33.33 %) P = 0.018 |
Forceps/vacuum | 47 (8.87 %) | 7 (11.11 %) P = 0.558 | 2 (4.76 %) P = 0.566a |
Bloody amniotic fluid | 11 (2.07 %) | 2 (3.17 %) P = 0.638a | 2 (4.76 %) P = 0.246a |
Meconium-stained amniotic fluid | 73 (13.75 %) | 9 (14.29 %) P = 0.907 | 4 (9.52 %) P = 0.440 |
Placental/fetal mass ratio (%) | 16.6 % | 16.2 % P = 0.51b | 17.8 % P = 0.46b |